SquareMind

Health Tech & Medtech · Paris, France · Founded 2019

Creating autonomous robots that will help healthcare professionals save time and improve patient care MoreLess

Developer of robotic medical equipment designed to transform non-invasive healthcare. The company's medical equipment is equipped with third-dimension construction software for full-body mapping to detect skin cancer, enabling physicians to track the growth of moles on the body using off-the-shelf robots. Keywords: Healthcare Devices, Services, Supplies, Cancer Detection, Cancer Detection Equipment, Medical Equipment, Oncology Device, Oncology Robots, Robotics Medical Equipment.

Valuation $0–100M

Revenue <$1M

Headcount <100

Total funding $10–50M

Unlock exact values

Company overview

SquareMind company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2019
Headquarters: Paris, France
Employees: 20
Open positions: None listed
Dealroom signal: 82.8

Website ↗LinkedIn ↗

client focusb2btechnologyArtificial IntelligencetechnologyDeep TechtechnologyMachine LearningtechnologyDeep LearningtechnologyComputer Visionsub industryMedical Devicessub industryHealth Platformbusiness modelSaaSindustryHealthsectorDermatologysectorCore AIsectorHealth DiagnosticssectorEIC

Valuation & funding

SquareMind funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Apr 2026	$18M	$72M	Adamed Group · Calm/Storm Ventures · Bpifrance · Sonder Capital	↗
SEED✓Equity / VC	Jun 2023	—	—	Undisclosed	—
GRANT✓Other financing	Jun 2021	$2.5M	—	European Innovation Council	—
ANGELEquity / VC	Feb 2021	$0	—	id4 Ventures · Entrepreneurs First · Calm/Storm Ventures	—
SUPPORT PROGRAM✓Other financing	Jan 2020	$2K	—	EIT Health	—

Showing 5 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

Year	Revenue	Growth	Employees
2026	$900K	0%	21
2025	$900K	0%	15
2024	$900K	0%	11
2023	$900K	0%	11
2022	$900K	—	12

Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

SquareMind website traffic

Latest recorded traffic for SquareMind is 50 monthly website visits, down 73.7% over the last three months. SquareMind's team grew 33.3% over the past year.

Latest monthly visits50 3-month web change-73.7% 1-year team growth+33.3%

Monthly website visits61 observations · Nov 2018–Jul 2026

Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

SquareMind compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
GRGanymed RoboticsGanymed retools orthopaedics with robotics. Their product is a compact, ergonomic, and cost-effective joint-replacement device. The robot's intelligence and perception are driven by computer vision	Paris, France	Operational	31	$44M	$116M
AGAgenTDeveloping the first blood diagnosis to detect Alzheimer’s disease while it’s still in the silent phase	Paris, France	Operational
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
RORobeautéWe are developing a sub millimetric microrobot that moves in the brain in curved lines (3D) with sub millimetric precision allowing to access complex areas of the brain in multiple locations to gather data and deliver cargos (micro-electrodes, drugs)	Paris, France	Operational
GLGleamerProviding imaging users a suite of Artificial Intelligence solutions covering a wide range of clinical applications	Saint-Mandé, France	Acquired
INinHEARTAI-enabled digital twin of the heart	Pessac, France	Operational
AZAZmedThe first French company to commercialize an AI-powered radiology software	Paris, France	Operational
IMImplicityDevelops a universal remote monitoring platform for cardiac patients with connected pacemakers and implantable defibrillators	Paris, France	Operational

Showing 8 of the closest matchesCompare every metric →

Talent graph

SquareMind's talent

Book a demo to see the people

Team profiled 7 named & role-tagged

Founders /100 quality score

Key operators 2 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on SquareMind's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 4 investors entered at this stage

id4 Ventures

Entrepreneurs First

Calm/Storm Ventures

European Innovation Council

Series A 4 investors entered at this stage

Adamed Group

Bpifrance

Sonder Capital

Teampact Ventures

Other known 2 additional known investors

EIT Health

Alban Oudin

Global footprint

Where SquareMind has talent and traffic

Workforce by country

4 countries with
team presence

🇫🇷 France83.3%

🇺🇸 United States5.6%

🇳🇱 Netherlands5.6%

🇨🇦 Canada5.6%

4 countries shown

In the news

Latest news about SquareMind

Recent press, funding announcements, and product moves mentioning SquareMind — open to read from the original sources.

See all news

Market sentiment

What the market is saying about SquareMind

An AI-synthesized read of the highest-engagement posts about SquareMind on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SquareMind’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.